Proqr Therapeutics N.v. · NASDAQ:PRQR

Filius Bart bought 150,000 Proqr Therapeutics N.v. shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 30, 2026

On Jun 26, 2026, Filius Bart (Director) bought 150,000 Proqr Therapeutics N.v. shares at US$1.54 for US$231K, leaving 150,000 shares. Filed Jun 30, 2026 (Form 4).

Bought
150,000 shares
Price
US$1.54
Value
US$231K
Holding after
150,000 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Ordinary SharesBuy150,000US$1.54150,000Direct

Source

View original at SEC

Related